case review: idh2-mutated acute myeloid leukemia
Published 6 years ago • 94 plays • Length 1:51Download video MP4
Download video MP3
Similar videos
-
2:15
case presentation: idh2-mutated aml
-
7:06
case 3: idh2-mutated aml
-
1:27
how do targeted treatments for idh1 and idh2 mutations work in acute myeloid leukemia (aml)?
-
7:09
aml on the go: targeted therapy of idh1/idh2 mutated aml
-
5:29
case 3: idh inhibitors for the treatment of aml
-
2:38
managing treatment for idh2-mutated aml
-
2:10
aml: significance of the idh2 mutation
-
3:22
case-based overview: newly diagnosed acute myeloid leukemia
-
0:50
combining azacitadine/enasidenib to enhance the treatment of newly diagnosed idh2-mutant aml
-
2:11
advantages of oral enasidenib in idh2-mutated aml
-
1:54
david sallman, md, on what the idh2 mutation reveals about the prognosis in acute myeloid leukemia
-
6:46
case 2: aml with myelodysplasia-related changes
-
4:05
enasidenib in relapsed/refractory mutant idh2 aml
-
3:23
the prognostic value of idh1 and idh2 in acute myeloid leukemia (aml)
-
1:26
expert explores potential role of doublets and triplets in idh1-mutant acute myeloid leukemia
-
6:10
targeting idh1/2 in aml
-
1:19
dr. eytan stein on targeting mutations in acute myeloid leukemia
-
3:10
case 1: flt3 aml
-
6:25
case 3: targeting idh in aml